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Interleukin-10 functions as a general immunosuppressive cytokine, which also negatively regulates inflammatory responses through complex mechanisms. Recent studies suggested that IL-10 may also inhibit fibrosis in various diseased models. However, the role of IL-10 in renal fibrosis has not been demonstrated. Here, we investigated the effects of IL-10 in the development of renal tubulointerstitial fibrosis by creating the unilateral ureteral obstruction (UUO) model in IL-10 knockout ( À / À ) mice. We performed sham or unilateral ureteral obstruction surgery in 8-week-old IL-10 À / À male mice and age and sex-matched wild type littermates. Mice were killed at 7 days or 14 days post surgery and renal tissues were obtained for RNA, protein, and immunohistochemical analysis. Our results found IL-10 deficiency resulted in enhanced renal fibrosis demonstrated by more severe tubular injury and collagen deposition and higher expression of pro-fibrotic genes (including a-SMA, MMP-2, fibronectin, FSP-1 and vimentin). Our results also found IL-10 À / À UUO mice developed more severe renal inflammation with a significant increase in inflammatory cells infiltration, and upregulation of inflammatory chemokines (MCP-1 and RANTES), and cytokines (TNF-a, IL-6, IL-8, and M-CSF). Further study revealed that enhanced renal inflammation and fibrosis was associated with significantly increased activation of both TGF-b/Smad3 and NF-kB signaling pathways. In summary, our study provides the direct evidence that IL-10 is an endogenous cytokine that has a key role in protecting against development of renal inflammation and fibrosis. Enhancement of IL-10 expression could be a potential anti-fibrosis therapy for patients with chronic kidney diseases. KEYWORDS: fibrosis; inflammation; interleukin-10; kidney; unilateral ureteral obstruction Interleukin-10 (IL-10) is a key immunosuppressive cytokine produced by regulatory T cells and other cells. 1 Its main biological function is to limit innate as well as adaptive immune responses and to protect host from immunemediated tissue damage. 2, 3 However, further studies reveal that IL-10 also has pivotal roles in suppressing inflammatory processes, mainly through blocking activation of inflammatory pathways and inhibiting the secretion of a broad spectrum of pro-inflammatory mediators, like IL-1, IL-6, IL-8, IL-12, interferon-g (IFN-g), tumor necrosis factor-a (TNF-a), chemokine monocyte chemoattractant protein-1 (MCP-1), and macrophage inflammatory protein (MIP)-1, and IL-8. [4] [5] [6] [7] In addition, IL-10 has been recently shown to inhibit fibrosis in various animal models. IL-10 treatment could attenuate the severity of liver fibrosis induced by carbon tetrachloride (CCl4) in vivo. 8 Several clinical studies also showed that IL-10 was able to reverse liver fibrosis without increasing viral titers in patients with chronic hepatitis C infection. 9 The role of IL-10 in fibrosis has been also reported in other organs such as lung, heart and pancreas fibrosis. [10] [11] [12] The underlying mechanism of antifibrotic effects of IL-10 remains unclear, but it has been suggested that IL-10 can suppress extracellular matrix synthesis and inhibit key inflammatory pathways such as NF-kB. [13] [14] [15] In the context of kidney, IL-10 has been reported to effectively suppress the progression of acute and chronic renal damage in vivo. [16] [17] [18] [19] [20] [21] [22] However, the role of IL-10 in renal tubulointerstitial fibrosis has not been studied. Here, we used IL-10 À / À mice [23] [24] [25] [26] with unilateral ureteral obstruction (UUO), a well-established model for kidney fibrosis, to investigate the roles of IL-10 in the progression of renal fibrosis.
MATERIALS AND METHODS
Animals and Experimental Protocol IL-10 À / À mice on C57BL/6 background obtained from Jackson Laboratory (Bar Harbor, Maine, CT, USA) were bred in the laboratory animal center at the Shanghai Jiao Tong University, School of Medicine. Male IL-10 À / À and wildtype (WT) littermates on B6 background (n ¼ 6/group) at 8 weeks of age underwent left ureteral obstruction or had sham operation. For mice in the UUO group, the left ureter was exposed through a mid-abdominal incision and ligated using 4-0 silk. All surgeries were performed under general anesthesia with isoflurane. All procedures were performed in accordance with the guidelines established by National Research Council Guide for the Care and Use of Laboratory Animals and approval of our Institute Animal Care and Use Committee (IACUC). Sham and UUO kidneys were harvested at day 7 or day 14 post-surgery.
RNA Isolation and Quantitative Real-Time PCR Total RNAs was isolated from mouse kidney using the RNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer. RT-PCR was carried out using the Bio-Rad iScript cDNA Synthesis kit. Quantitative real-time PCR with SYBR green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) was performed in a MicroAmp Fast Optical 384-Well Reaction Plate (Applied Biosystems) using the 7300 Fast Real-Time PCR System (Applied Biosystems) for thermal cycling and real-time fluorescence measurements. Lightcycler analysis software was used for determining crossing points based on the second derivative method. Data were analyzed by the 2 À DDCT methods and presented as fold change relative to a control sample after normalization against the expression of housekeeping genes. The sequences of the primer sets are given in Table 1 .
Western Blot Analysis
Protein from homogenized frozen kidney was prepared in a lysis buffer. After sonication and centrifugation, supernatants were collected, and the protein concentration was determined with the BCA protein assay kit (Pierce, Rockford, IL, USA). Western blotting was performed as previously described. 22, 30 The primary antibodies were obtained from the following sources: anti-phospho-p65 (no. 3039), anti-phospho-Smad3 (no. 9520), anti-glyceraldehyde-3-phosphate dehydrogenase (no. 2118) (Cell Signaling Technology, Danvers, MA, USA). Anti-rabbit antibody conjugated with horseradish peroxidase Figure 1 Determination of IL-10 mRNA levels in mice kidney by real-time PCR. IL-10 mRNA levels were increased markedly in WT mouse kidney after UUO. However, IL-10 mRNA levels were undetectable in IL-10-deficient mice. Relative mRNA levels (fold induction over sham controls) were reported after normalization with GAPDH, Interleukin-10 in UUO mice Y Jin et al was used as secondary antibody, and visualized using chemiluminescent substrate (SuperSignal; Pierce Chemical Co.). Quantification was performed by measuring the intensity of the bands with the use of the National Institutes of Health Image analysis software.
Histology and Immunohistochemistry
Histology scoring was performed by examining PAS-stained kidney sections of six mice in each group by an experienced pathologist on coded slides. The percentage of injured tubules in the cortex was estimated using a four-point scale by using the following criteria: tubular dilatation, epithelial simplification, and interstitial expansions in 10 randomly chosen, non-overlapping fields ( Â 400). Lesions were graded on a scale from 0 to 4: 0 ¼ normal; 1 ¼ mild, involvement of o25% of the cortex; 2 ¼ moderate, involvement of 25-50% of the cortex; 3 ¼ severe, involvement of 50-75% of the cortex; 4 ¼ involving 475% of the cortex. Picrosirius Red staining was performed for assessment of collagen deposition as described. 27 The amount of cortical fibrillary collagen was determined by observing areas stained with picrosirius red with a Zeiss Axioplan 2IE microscope. Twenty non-overlapping fields at Â 400 magnification from each section were analyzed in a blinded manner and quantified using a digital image analysis program (MetaMorph7.6). Results are expressed as a percentage of the area with picrosirius red staining.
Indirect immunoperoxidase procedure was performed using a microwave-based antigen retrieval technique. 28 Paraffin-embedded sections were stained with polyclonal goat anti-Collagen I antibody (Southern Biotech, Birmingham, AL, USA), monoclonal rat anti-F4/80 antibody (AbD Serotec, Oxford, UK), polyclonal rabbit anti-a-SMA antibody and 
Hydroxyproline Assay
Collagen content was assessed by hydroxyproline assay according to the method of Samuel CS. 29 One-fourth of the obstructed or contralateral kidney was completely hydrolyzed in 1 ml 6 N HCl by incubation at 110 1C for 18 h, before being neutralized with 10 N NaOH and lyophilized. The obtained Interleukin-10 in UUO mice Y Jin et al dried residues were reconstituted with 0.1 M HCl and oxidized by chloramines-T for 4 min at room temperature. Then samples were mixed with p-dimethylaminonbenzaldehyde and placed for 25 min in a shaking water bath at 60 1C. The absorbance was measured at 558 nm using a spectrophotometer. Hydroxyproline content was calculated from the standard curve constructed with cis-4-hydroxy-L-proline (Sigma). The results were expressed as total collagen/kidney tissue, assuming that collagen contains an average of 14.4% hydroxyproline.
Statistical Analysis
All data are presented as mean ± standard deviation (X ± s.d.). A nested ANOVA was used for all semiquantitative computer-assisted image analysis. For image analysis data, the arithmetic mean of six randomly selected images of slides for each animal was used to calculate the reported mean of the group and the s.d. All other results were analyzed by unpaired t-test between two groups after determination of data distribution. The Bonferroni correction was used when more than two groups were present. Po0.05 was considered statistically significant.
RESULTS

IL-10 Expression in Mouse Kidney Tissues
We firstly examined the mRNA levels of IL-10 in mouse kidneys of different groups by real-time PCR. As shown in Figure 1 , IL-10 mRNA levels were nearly 25-fold higher in kidneys of WT UUO mice than those of control mice. However, IL-10 mRNA levels were undetectable in IL-10-deficient mouse kidneys. These data suggest that the endogenous anti-inflammatory cytokine IL-10 is upregulated in UUO kidneys. We also confirmed here the knockout of IL-10 gene in IL-10-deficient mice.
IL-10 Deficiency Induces More Severe Tubular Injury in Obstructed Kidneys
To study the role of IL-10 in the progression of renal fibrosis, we firstly analyzed tubular injury scores using PAS-stained kidney sections from these mice. As shown in Table 2 , we found that WT mice demonstrated significant tubular injury after UUO. However, IL-10-deficient mice developed more severe tubular injury in the obstructed kidneys than WT mice at both 7 and 14 days after UUO.
IL-10 Deficiency Promoted Renal Fibrosis in UUO Mice
We first investigated the effects of IL-10 on the kidney collagen deposition. By specific staining of collagen I and real-time PCR, we found that both collagen protein accumulation ( Figure 2 ) and mRNA expression ( Figure 3a) were significantly increased in the obstructed kidneys of IL-10 À / À mice compared with WT mice at each time point. This was further confirmed by quantification of the collagen content in the kidney as determined by measurement of hydroxyproline, a major component of collagen (Figure 3b ).
We also determined the activation of myofibroblasts in the kidneys of these mice. We found more prominent increase in staining for a-smooth muscle actin (a-SMA) (Figures 4a-g ) and higher levels of a-SMA mRNA (Figure 4h ) in obstructed kidneys of IL-10 À / À mice as compared with those of WT mice. These results suggested that IL-10 deficiency induced more severe renal fibrosis.
IL-10 Deficiency Induced Pro-Fibrotic Gene Expression in the UUO Kidney Next, we examined the expression of several pro-fibrotic markers in kidneys of these mice by real-time PCR. As shown in Figure 5 , UUO caused a dramatic induction of the mRNA expression of pro-fibrotic genes, including fibronectin, matrix metalloproteinase-2 (MMP-2), fibroblast-specific protein-1(FSP-1) and vimentin, in the UUO kidneys than the sham-operated ones. The increase of these genes was much higher in IL-10 À / À UUO mice than WT UUO mice. These results suggest that IL-10 deficiency promotes key profibrotic genes expression in the UUO kidney.
IL-10 Deficiency Induced Inflammatory Cells Infiltration and Inflammatory Cytokines Expression in the UUO Mice
Inflammation has a critical role in the renal tubulointerstitial fibrosis. To explore the potential mechanism involved in antifibrotic effects of IL-10 in the UUO model, we examined inflammatory response in both UUO and control mice. As shown in Figure 6 , there were only a few of F4/80 þ macrophages and CD3 þ T cells in kidneys of control groups. At day 7 and day 14 after UUO, infiltration of F4/80 þ macrophages and CD3 þ T cells progressively increased in the interstitial areas of the obstructed kidneys more in IL-10 À / À mice than in WT mice. We also examined the effects of Figure 5 Deletion of IL-10 up-regulates fibrotic genes expression in the obstructed kidney. Representative real-time PCR analysis and quantitative data show that IL-10 deficiency increased renal MMP-2, fibronectin, FSP-1, and vimentin mRNA expression after obstructive injury. Relative mRNA levels (fold induction over sham controls) were reported after normalization with GAPDH, respectively. *Po0.05, DPo0.01. 
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Y Jin et al IL-10 on the expression of chemokines, including MCP-1 and RANTES, as well as pro-inflammatory cytokines, including TNF-a, IL-6, IL-8 and macrophage-colony stimulating factor (M-CSF), which were important molecules that mediated macrophage and T cell chemotaxis. As shown in Figure 7 , compared with WT groups, expression of MCP-1, TNF-a, IL-6, IL-8 and M-CSF were upregulated more in IL-10 À / À mice at day 7 and day 14 after UUO. Expression of RANTES was also increased but there was no significant difference between WT UUO and IL-10 À / À UUO mice.
IL-10 Deficiency Induces More Activation of Inflammatory and Fibrosis Pathways in the UUO Kidney
To better understand potential mechanisms by which IL-10 regulated renal inflammatory and fibrotic response, we examined activities of TGF-b and NF-kB pathways, which are known to have critical roles in the progression of renal fibrosis ( Figure 8 ). We found phosphorylated Smad3 and p65 were weakly expressed in the kidneys of sham-operated mice. A marked increase of these phosphorylated proteins was observed in WT mice as early as 7 days after UUO. However, there was more increase of Smad3 and p65 phosphorylation in IL-10 À / À UUO mice than WT UUO mice at both 7 days and 14 days after UUO. These data suggests that IL-10 deficiency may significantly enhance the activation of key pro-inflammatory and pro-fibrosis pathways in the UUO kidney.
DISCUSSION
Renal tubulointerstitial fibrosis is the final common pathway leading to end-stage renal disease (ESRD) in various types of renal diseases and its severity correlates strongly with the inflammatory status. Elucidation of the primary mechanisms involved in tubulointerstitial fibrosis is an important step toward developing new therapies to prevent progressive kidney diseases resulting in ESRD. IL-10 is a general immunosuppressive cytokine and has been proved to negatively regulate inflammatory responses and inhibit fibrosis in various diseased models. However, the relationship between IL-10 and tubulointerstitial fibrosis is not fully understood. The present study was the first one to examine the role of IL-10 in the process of interstitial fibrosis using the UUO model, which has been widely used as an animal model of tubulointerstitial disease. We found that IL-10 deficiency deteriorated tubular injuries and promoted renal fibrosis in the kidney of UUO mice. We also found IL-10 deficiency lead to more severe inflammatory cell infiltration (macrophage and T cells) and higher expression of pro-inflammatory cytokines (TNF-a, IL-6, M-CSF, and IL-8) and chemokines (MCP-1, RANTES). Additionally, TGF-b/Smad3 and NF-kB pathways were activated more in IL-10 À / À UUO mice than in WT UUO mice. These findings provide evidence that IL-10 has a critical role in protecting against development of renal inflammation and fibrosis. Interleukin-10 in UUO mice Y Jin et al role of IL-10 in attenuating renal fibrosis. Studies in other organs, including lung, heart, pancreas and liver, also showed IL-10 could suppress inflammatory response and thereby inhibit matrix remodeling and fibrosis process, even if fibrosis had developed. [31] [32] [33] [34] [35] [36] [37] Here, we provide direct evidence supporting the role of IL-10 in renal fibrosis by demonstrating that knockout of IL-10 leads to more severe inflammatory response and renal injury and fibrosis in the UUO model. In addition, we found that knockout of IL-10 enhanced activation of TGF-b/Smad3 and NF-kB pathways at days 7 and 14 after UUO, which are known to have central roles in the initiation and progression of renal inflammation and fibrosis through inducing a wide array of genes encoding pro-inflammatory cytokines, adhesion molecules, and chemokines in human and experimental models of kidney diseases. These results are also consistent with previous studies suggesting IL-10 mediates anti-inflammation and anti-fibrotic effects through negatively regulating these signaling pathways. [38] [39] [40] [41] [42] [43] [44] It has been shown that the treatment with IL-10 could inhibit TGF-b and NF-kB activation to reduce inflammatory response, ECM production and fibrotic genes expression in animal models of pulmonary and hepatic fibrosis. 34, 45 In summary, the present study suggests that the deficiency of IL-10 aggravates inflammation and fibrosis in obstructive kidney disease. This was associated with the loss of inhibitory effects of IL-10 on inflammatory pathways, including TGF-b/Smad3 signaling pathway and NF-kB signaling pathway. Thus, IL-10 may be a critical negative regulator in renal inflammation and fibrosis. Results from this study further support the notion that IL-10 could be a therapeutic agent for kidney fibrotic diseases.
